First Time Loading...

Sumitomo Pharma Co Ltd
TSE:4506

Watchlist Manager
Sumitomo Pharma Co Ltd Logo
Sumitomo Pharma Co Ltd
TSE:4506
Watchlist
Price: 410 JPY 2.5% Market Closed
Updated: Apr 30, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Sumitomo Pharma Co Ltd

Wall Street analysts forecast Sumitomo Pharma Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Sumitomo Pharma Co Ltd is 435.69 JPY with a low forecast of 252.5 JPY and a high forecast of 913.5 JPY.

Lowest Forecast
Wall Street Target
252.5 JPY
38% Downside
Average Forecast
Wall Street Target
435.69 JPY
6% Upside
Highest Forecast
Wall Street Target
913.5 JPY
123% Upside
Lowest
Price Target
252.5 JPY
38% Downside
Average
Price Target
435.69 JPY
6% Upside
Highest
Price Target
913.5 JPY
123% Upside
Sumitomo Pharma Co Ltd Competitors:
Price Targets
LUPIN
Lupin Ltd
14% Downside
KOPRAN
Kopran Ltd
72% Downside
R
000650
Renhe Pharmacy Co Ltd
104% Upside
524731
Jenburkt Pharmaceuticals Ltd
31% Downside
LUPIN
Lupin Ltd
14% Downside
KOPRAN
Kopran Ltd
72% Downside
R
000650
Renhe Pharmacy Co Ltd
104% Upside
524731
Jenburkt Pharmaceuticals Ltd
31% Downside
TLRY
Tilray Brands Inc
36% Upside
R
RHONEMA
Rhone Ma Holdings Bhd
23% Upside
ERIS
Eris Lifesciences Ltd
18% Upside
BAI
BenevolentAI SA
286% Upside

Revenue
Forecast

Revenue Estimate
Sumitomo Pharma Co Ltd

For the last 8 years the compound annual growth rate for Sumitomo Pharma Co Ltd's revenue is 5%. The projected CAGR for the next 3 years is -12%.

5%
Past Growth
-12%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Sumitomo Pharma Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Sumitomo Pharma Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
14%
Average Beat
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Sumitomo Pharma Co Ltd's stock price target?
Price Target
435.69 JPY

According to Wall Street analysts, the average 1-year price target for Sumitomo Pharma Co Ltd is 435.69 JPY with a low forecast of 252.5 JPY and a high forecast of 913.5 JPY.

What is Sumitomo Pharma Co Ltd's Revenue forecast?
Projected CAGR
-12%

For the last 8 years the compound annual growth rate for Sumitomo Pharma Co Ltd's revenue is 5%. The projected CAGR for the next 3 years is -12%.

ALPHA SPREAD
Join more than 132,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.